Phase III Trial of MC2-01 Cream for Plaque Psoriasis Shows Efficacy and Safety
A Phase III trial is underway to evaluate the efficacy and safety of MC2-01 cream compared to existing treatments in plaque psoriasis.
Company
Pharmaceutical intelligence for Hangzhou Zhongmei Huadong Pharmaceutical with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No signals indexed for this entity yet.
No signals indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.